1. 0453 Lemborexant Exposure Is Independent of Race. (25th May 2022) Authors: Rawal, Sumit; Landry, Ishani; Lalovic, Bojan; Nakai, Kenya; Kubota, Naoki; Moline, Margaret Journal: Sleep Issue: Volume 45(2022)Supplement 1 Page Start: A201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dexmedetomidine Pharmacokinetics in Neonates with Hypoxic-Ischemic Encephalopathy Receiving Hypothermia. (25th February 2020) Authors: McAdams, Ryan M.; Pak, Daniel; Lalovic, Bojan; Phillips, Brian; Shen, Danny D. Other Names: Pearl Ronald G. Academic Editor. Journal: Anesthesiology research and practice Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of the CYP3A and CYP2B6 Drug‐Drug Interaction Potential of Lemborexant. Issue 6 (17th January 2021) Authors: Landry, Ishani; Aluri, Jagadeesh; Nakai, Kenya; Hall, Nancy; Miyajima, Yukiko; Ueno, Takashi; Dayal, Satish; Filippov, Gleb; Lalovic, Bojan; Moline, Margaret; Reyderman, Larisa Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 6(2021) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Exposure–Response Analyses of Polysomnography and Subjective Sleep Efficacy End Points From the Phase 3 Trials of Lemborexant, a Dual Orexin Receptor Antagonist for the Treatment of Insomnia. (17th January 2023) Authors: Lalovic, Bojan; Savant Landry, Ishani; Moline, Margaret; Reyderman, Larisa; Hussein, Ziad Journal: Journal of clinical pharmacology Issue: Volume 63:Number 4(2023) Page Start: 498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study. Issue 10080 (29th April 2017) Authors: Feagan, Brian G; Sandborn, William J; D'Haens, Geert; Panés, Julián; Kaser, Arthur; Ferrante, Marc; Louis, Edouard; Franchimont, Denis; Dewit, Olivier; Seidler, Ursula; Kim, Kyung-Jo; Neurath, Markus F; Schreiber, Stefan; Scholl, Paul; Pamulapati, Chandrasena; Lalovic, Bojan; Visvanathan, Sudha; ... Journal: Lancet Issue: Volume 389:Issue 10080(2017) Page Start: 1699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single‐Dose and Multiple‐Ascending‐Dose Phase 1 Studies in Healthy Adults. Issue 2 (28th May 2020) Authors: Landry, Ishani; Nakai, Kenya; Ferry, Jim; Aluri, Jagadeesh; Hall, Nancy; Lalovic, Bojan; Moline, Margaret L. Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 2(2021) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Physiologically‐based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors. (1st May 2021) Authors: Ueno, Takashi; Miyajima, Yukiko; Landry, Ishani; Lalovic, Bojan; Schuck, Edgar Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 5(2021) Page Start: 455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Population Pharmacokinetics and Exposure‐Response Analyses for the Most Frequent Adverse Events Following Treatment With Lemborexant, an Orexin Receptor Antagonist, in Subjects With Insomnia Disorder. (14th July 2020) Authors: Lalovic, Bojan; Majid, Oneeb; Aluri, Jagadeesh; Landry, Ishani; Moline, Margaret; Hussein, Ziad Journal: Journal of clinical pharmacology Issue: Volume 60:Number 12(2020) Page Start: 1642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Risk‐Based Pharmacokinetic and Drug–Drug Interaction Characterization of Antibody–Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development Perspective. Issue 4 (23rd November 2021) Authors: Li, Chunze; Menon, Rajeev; Walles, Markus; Singh, Renu; Upreti, Vijay V.; Brackman, Deanna; Lee, Anthony J.; Endres, Christopher J.; Kumar, Seema; Zhang, Donglu; Barletta, Frank; Suri, Ajit; Hainzl, Dominik; Liao, Kai H.; Lalovic, Bojan; Beaumont, Maribel; Zuo, Peiying; Mayer, Andrew P.; Wei... Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 4(2022) Page Start: 754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗